PKVitality develops the K'Watch, a bio-wearable smartwatch that continuously monitors glucose and lactate levels using non-invasive sensors. This technology provides real-time health data to individuals managing diabetes or athletes optimizing performance, addressing the need for accurate and convenient monitoring solutions.
Funding
$6.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Individuals managing diabetes or athletes optimizing performance need accurate and convenient methods to continuously monitor glucose and lactate levels. Traditional monitoring methods often involve invasive procedures and bulky equipment, limiting accessibility and real-time insights.
Solution
PKVitality develops the K'Watch, a bio-wearable smartwatch that provides continuous, real-time monitoring of glucose or lactate levels through a sensor array. The K'Watch aims to combine the accuracy of a medical device with the ease of use of a consumer electronic device. The device is designed to track glucose levels for individuals managing diabetes and lactate levels for athletes seeking to optimize their training. Data is transmitted to a companion app, providing users with personalized insights and trends to inform proactive health management and performance adjustments.
Target Audience
The primary target audience includes individuals with diabetes seeking continuous glucose monitoring and athletes aiming to optimize performance through lactate level tracking.
Features
- Continuous glucose or lactate monitoring via a non-invasive sensor array
- Real-time data displayed on a smartwatch interface
- Integration with a mobile app for data visualization and trend analysis
- Alerts and notifications based on user-defined thresholds
- Data logging for historical tracking and analysis
- Designed for both glucose monitoring for diabetes management and lactate monitoring for athletic performance